Underdiagnosed. Under‑represented. Underwhelming outcomes. We know that there is much work to be done to bridge the PCI gender inequality gap, so we’re committing our expertise, clinical focus and technological advances to do everything we can to narrow the gap.SCAI 2022 Data
The largest gender specific OCT analysis demonstrates excellent stent expansion and MSA post-IVL with impressive procedural safety in both women and men.
The long-term gender analysis of coronary IVL finds sustained positive clinical outcomes with excellent safety in both women and men at one year.
Some of us know the data. Some don’t. The question once you do is where we go from here to bridge the gender inequality gap? To help address this question, here is a great discussion hosted by SCAI Conversations in Interventional Cardiology with Drs. Alexandra Lansky, J. Dawn Abbott, Jennifer Tremmel, Roxana Mehran, and Suzanne Baron on the recently JSCAI published “Expert Consensus on Sex Specific Considerations in Myocardial Revascularization.”
JSCAI recently published an “Expert Consensus on Sex Specific Considerations in Myocardial Revascularization” which highlights gender disparities in coronary disease, guides future research priorities and suggests IVL as a potential first-line therapy in females with calcified lesions.Learn more
The SCAI-WIN mission is to foster professional development, education, collaboration, and research by and on behalf of women in interventional cardiology and their patients.
The Women As One mission is to promote talent in medicine, providing women physicians with unique professional opportunities. By doing this, Women As One aims to build a more inclusive, diverse and just workforce in medicine.
The Lancet Women in Cardiovascular Disease Commission, led by Dr. Roxana Mehran, summarizes existing evidence and identifies knowledge gaps in research, prevention, treatment, and access to care for women. It furthermore outlines ambitious new recommendations with a clear focus on reducing the global burden of cardiovascular disease in women by 2030.
Join us at SCAI 2022 to learn about new practice-changing coronary IVL data in females.
How It Started Vs How It’s Going: Coronary Calcium Modification Outcomes In Men Vs Women
Saturday, May 21 • 12:30 PM - 1:30 PM
Regency VI Ballroom Level (LL1)
Sex-specific OCT characterization of IVL treatment of calcified coronary lesions: Patient-level pooled analysis of the Disrupt CAD OCT sub-studies
Saturday, May 21 • 12:00 PM - 12:30 PM • Grand Hall Foyer, Exhibit Level - LL2 (D-8) • Nadia Sutton, MD, University of Michigan
Sex-specific 1-year outcomes in coronary IVL for treatment of severely calcified coronary lesions: A patient-level pooled analysis of the Disrupt CAD III and CAD IV studies
Saturday, May 21 • 1:30 PM - 2:00 PM • Grand Hall Foyer, Exhibit Level - LL2 (E-19) • Alexandra Lansky, MD, Yale University